NASDAQ:LIFE
aTyr Pharma Stock News
$1.95
-0.0500 (-2.50%)
At Close: Mar 28, 2024
Pharmsynthez PJSC Secures RUB 800m With LDA Capital
01:00am, Thursday, 24'th Jun 2021
LOS ANGELES--(BUSINESS WIRE)---- $LIFE #CapitalCommitment--Russian listed pharmaceutical manufacturer, Pharmsynthez PJSC (MOEX:LIFE), secures 800 million rubles from global alternative investor, LDA C
aTyr Pharma to Host Virtual Key Opinion Leader Event on Current Treatment Options for Pulmonary Sarcoidosis
08:00am, Wednesday, 23'rd Jun 2021
Event will feature Dr. Daniel Culver, Director of the Interstitial Lung Disease Program at the Cleveland Clinic.
aTyr Pharma Presents Poster Demonstrating Functional Selectivity of Second Anti-NRP2 Antibody
04:30pm, Thursday, 10'th Jun 2021
Preclinical candidate is second to demonstrate selective blocking ability from in-house panel of antibodies targeting NRP2.
Week In Review: Genscript And Its Legend Bio Subsidiary Raise $1 Billion From Hillhouse
02:52pm, Sunday, 16'th May 2021
Genscript raised more than $1 billion from Hillhouse Capital in several different investments, including a $500 million commitment to Genscript's Legend Biotech CAR-T subsidiary. Shanghai Fosun Pharma
aTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q1 2021 Results - Earnings Call Transcript
11:38pm, Thursday, 13'th May 2021
aTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q1 2021 Results - Earnings Call Transcript
Atyr Pharma (LIFE) Reports Q1 Loss, Lags Revenue Estimates
06:11pm, Thursday, 13'th May 2021
Atyr Pharma (LIFE) delivered earnings and revenue surprises of -50.00% and -100.00%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Atyr Pharma (LIFE) to Report a Decline in Earnings: What to Look Out for
03:47pm, Tuesday, 04'th May 2021
Atyr Pharma (LIFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
aTyr Pharma and Foundation for Sarcoidosis Research Announce Town Hall Virtual Meeting on Steroids and Sarcoidosis
08:00am, Tuesday, 20'th Apr 2021
Panel discussion on steroids and sarcoidosis to be held on Tuesday, April 27 at 12:00pm ET / 3:00pm PT Panel discussion on steroids and sarcoidosis to be held on Tuesday, April 27 at 12:00pm ET / 3:00
Findings demonstrate tumor inhibitory effects of ATYR2810 when used as a monotherapy or in combination with chemotherapy in models of non-small cell lung cancer.
aTyr Pharma, Inc. (LIFE) CEO Dr. Sanjay Shukla on Q4 2020 Results - Earnings Call Transcript
08:49pm, Tuesday, 23'rd Mar 2021
aTyr Pharma, Inc. (LIFE) CEO Dr. Sanjay Shukla on Q4 2020 Results - Earnings Call Transcript
aTyr Pharma: Q4 Earnings Insights
04:46pm, Tuesday, 23'rd Mar 2021
Shares of aTyr Pharma (NASDAQ:LIFE) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 69.48% over the past year to ($0.47), which beat the
aTyr Pharma Announces Fourth Quarter and Full Year 2020 Results and Provides Corporate Update
04:05pm, Tuesday, 23'rd Mar 2021
Completed enrollment of ATYR1923 clinical trial in patients with pulmonary sarcoidosis. Data is expected in the third quarter.
Atyr Pharma (LIFE) Moves 26.3% Higher: Will This Strength Last?
03:02am, Wednesday, 17'th Mar 2021
Atyr Pharma (LIFE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
LIFE Stock: Increased Price Target Gives aTyr Pharma Shares a Big Lift
02:21pm, Tuesday, 16'th Mar 2021
Atyr Pharma (LIFE) stock is taking off on Tuesday after getting a price target update from Roth Capital analyst Zegbeh Jallah. The post LIFE Stock: Increased Price Target Gives aTyr Pharma Shares a Bi
7 Stocks With Important Insider Trading Signals That Say Sell
01:55pm, Friday, 12'th Feb 2021
These seven names have shown important insider trading signals after their rallies, meaning some insiders are taking profits in these stocks. The post 7 Stocks With Important Insider Trading Signals T